Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Active Rheumatoid Arthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01261403
Recruitment Status : Terminated (Enrollment terminated pending additional Phase 1 data)
First Posted : December 16, 2010
Last Update Posted : March 2, 2018
Celgene Corporation
Information provided by (Responsible Party):
Celularity Incorporated

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : September 2013
  Certification/Extension First Submitted : August 13, 2013